Abstract
AbstractBackgroundDue to more infections from variations that could escape vaccination and immunity by asymptomatic to uninfected transmission, COVID-19’s second wave had higher seroprevalence globally. Public health constraints and herd immunity may not work against these novel variations’ infectivity. This population-based study in Peru’s Tumbes Region during the second wave of COVID-19 seeks to determine seroprevalence and demographic changes from the first wave.Methodology/Principal findingsIn Dec 2021-Jan 2022, a study in Tumbes’ informal settlement sampled individuals over 2 years old from one in every four households. Finger-prick blood samples and symptom surveys were collected. On the second wave, there was a substantial rise in adjusted seroprevalence (50.15%, 95% CI [45.92 – 54.40]) compared with the first wave (24.82 %, 95%CI [22.49 – 27.25]), with females maintaining a higher seroprevalence (53.89; 95% CI [48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compare to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave.Conclusions/SignificanceIn Tumbes, the seroprevalence of COVID-19 increased by twofold compared to the initial wave. Inadequate infrastructure and limitations in human resources and supplies in healthcare facilities made the Peruvian health system collapse. We must include in epidemiological surveillance mHealth tools that enable real-time reporting of new cases. Working alongside the community is the only way to improve any new intervention strategy to prevent or control a new pandemic.Author summaryIn Peru, the healthcare system was overwhelmed by the COVID-19 pandemic due to the lack of hospital capacity, oxygen supply, political unrest, and a fragmented healthcare system. During the first wave, the prevalence ranged from 20.8% to 72%, and it was predicted that the second wave would be disastrous. To assess the seroprevalence of SARS-CoV-2, a cross-sectional study was conducted in the settlement “AAHH Las Flores” located in front of Tumbes National University’s main campus. A door-to-door intervention was conducted, and a total of 580/781 (74.26%) individuals over than 2 years and above agreed to participate. After adjusting for sensitivity and specificity, the calculated adjusted seroprevalence was 50.15%. Women had a slightly higher adjusted seroprevalence compared to men, and the age groups with the highest prevalence of IgG seropositive were from 12 to 17 years, from 30 to 59 years, and older than 60 years. More than 80% of seropositive patients were asymptomatic in all age groups. The study’s findings suggest that COVID-19 transmission in the settlement was higher during the second wave, and asymptomatic individuals could have played a critical role in spreading the virus.
Publisher
Cold Spring Harbor Laboratory
Reference41 articles.
1. Some lessons that Peru did not learn before the second wave of COVID-19;Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, et al;Int J Health Plann Manage. mayo de,2021
2. Los tsunamis por Covid-19 en Perú: El primero malo, segundo peor;Mayta-Tristán P;Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo. julio de,2021
3. What does COVID-19 tell us about the Peruvian health system? Canadian Journal of Development Studies / Revue canadienne d’;tudes du développement,2021
4. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos;Álvarez-Antonio C, Meza-Sánchez G, Calampa C, Casanova W, Carey C, Alava F, et al;Peru in July and August, 2020: a population-based study. The Lancet Global Health. 1 de julio de,2021
5. Vargas-Herrera N, Araujo-Castillo RV, Mestanza O, Galarza M, Rojas-Serrano N, Solari-Zerpa L. SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence. The Lancet Regional Health – Americas [Internet]. 1 de febrero de 2022 [citado 16 de febrero de 2023];6. Disponible en: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00108-3/fulltext